Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1201608014 | Valproic acid 250mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1214586011 | Valproic acid 250mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3472423019 | Valproic acid 250 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3472424013 | Product containing valproic acid 250 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3490184015 | Product containing valproic acid 250 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568693015 | Product containing only valproic acid 250 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568694014 | Product containing only valproic acid 250 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683923015 | Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3683924014 | Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683925010 | Valproic acid 250 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 108306001000001116 | Valproic acid 250 mg/1 each oral capsule | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Is a | Product containing valproate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Is a | Product containing valproic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has active ingredient | Valproic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has active ingredient | Valproate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Is a | Product containing valproic acid in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has active ingredient | Valproic acid | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has basis of strength substance | Valproic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has precise active ingredient | Valproic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Is a | Product containing only valproic acid in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule | Plays role | Anticonvulsant therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR